5 employees
Virocarb is a antiviral biotech company which advancing innovative drugs for viral infections with critical unmet therapeutic needs.
2011
ViroCarb Inc. raised undisclosed on January 1, 2021
Investors: Creative Destruction Lab
ViroCarb Inc. raised undisclosed on January 1, 2020
Investors: UTEST, University of Toronto